Telomere dysfunction and evolution of intestinal carcinoma in mice and humans
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Telomerase activation is a common feature of advanced human cancers and facilitates the malignant transformation of cultured human cells and in mice. These experimental observations are in accord with the presence of robust telomerase activity in more advanced stages of human colorectal carcinogenesis. However, the occurrence of colon carcinomas in telomerase RNA (Terc)-null, p53-mutant mice has revealed complex interactions between telomere dynamics, checkpoint responses and carcinogenesis. We therefore sought to determine whether telomere dysfunction exerts differential effects on cancer initiation versus progression of mouse and human intestinal neoplasia. In successive generations of ApcMin Terc-/- mice, progressive telomere dysfunction led to an increase in initiated lesions (microscopic adenomas), yet a significant decline in the multiplicity and size of macroscopic adenomas. That telomere dysfunction also contributes to human colorectal carcinogenesis is supported by the appearance of anaphase bridges (a correlate of telomere dysfunction) at the adenoma-early carcinoma transition, a transition recognized for marked chromosomal instability. Together, these data are consistent with a model in which telomere dysfunction promotes the chromosomal instability that drives early carcinogenesis, while telomerase activation restores genomic stability to a level permissive for tumor progression. We propose that early and transient telomere dysfunction is a major mechanism underly…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We monitored the anaphase bridge index (ABI), an in vivo biomarker of the degree of telomere dysfunction in dividing tissues that mirrors chromosomal fusion frequency, in successive mTerc -/ -generations (7, 30) (see Materials and Methods for definition of ABI).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [30]
In the citing paper
“The GI crypts of lategeneration mTerc -/ -Ink4a / Arf + / + and -/ -mice exhibited equally high levels of apoptosis (Fig. 1 C ), comparable to that in late-generation mTerc -/ -tissues with intact p53 function (7, 30).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [30]
In the citing paper
“This finding differs from that of the mTerc Apc Min model, wherein telomere dysfunction promotes the initiation of intestinal carcinomas but inhibits their progression (30).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [30]
In the citing paper
“findings consistent with previous studies establishing that telomere dysfunction acts as a tumor suppressor when p53 function is intact (7, 8, 30, 48).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [30]
In the citing paper
“Crosses of telomerase-deficient mice with various tumour model mice have demonstrated that critically short telomeres limit tumour formation when the p53 pathway is functional51–55.”
From Telomeres in cancer: tumour suppression and genome instability (2017) · cites this paper as [52]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 1×
“gif" NDATA ITEM> ]> Telomerase activation is a common feature of advanced human cancer”
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168 · cited 1×
“Epithelial cancers occur infrequently in laboratory mice, and when they do occur they rarely exhibit the aberrant cytogenetic profiles typical of human carcinomas, such as severe aneuploidy and complex nonreciprocal translocation”
BackgroundCreation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345 · cited 1×
“and facilitates the malignant transformation of cultured human cell”
BackgroundTelomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Self-citationTRF2 Protects Human Telomeres from End-to-End Fusions
van Steensel, B., Smogorzewska, A., & de Lange, T. (1998) · Cell · doi:10.1016/s0092-8674(00)80932-0 · Cited by 1,709
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650 · cited 1×
“Together, the presence of short telomeres in colorectal carcinom”
BackgroundTHE STABILITY OF BROKEN ENDS OF CHROMOSOMES IN ZEA MAYS
McClintock, B. (1941) · Genetics · doi:10.1093/genetics/26.2.234 · Cited by 1,596
A Dominant Mutation That Predisposes to Multiple Intestinal Neoplasia in the Mouse
Moser, A. R., Pitot, H. C., & Dove, W. F. (1990) · Science · doi:10.1126/science.2296722 · Cited by 1,591 · cited 1×
“In successive generations of Apc Min Terc −/− mic”
BackgroundMultiple Intestinal Neoplasia Caused by a Mutation in the Murine Homolog of the APC Gene
Su, L.-K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A., & Dove, W. F. (1992) · Science · doi:10.1126/science.1350108 · Cited by 1,536
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349
Self-citation
Cited by
Items 201–300 of 521
Induction of a p95/Nbs1‐mediated S phase checkpoint by telomere 3′ overhang specific DNA
Eller, M. S., Li, G., Firoozabadi, R., Puri, N., & Gilchrest, B. A. (2003) · The FASEB Journal · doi:10.1096/fj.02-0197com · Cited by 60
“The apparent ability of oligonucleotides to induce this response in the absence of DNA damage and telomere disruption offers the possibility of “rejuvenating” cells through telomere elongation, as recently reported in human skin equivalent constructs containing fibroblasts transfected with TERT (68) but without the en…”
BackgroundStem cells, telomerase and dyskeratosis congenita
Mason, P. J. (2003) · BioEssays · doi:10.1002/bies.10229 · Cited by 65
“different genetic backgrounds lead to a model whereby telomere dysfunction causes the chromosomal instability that promotes the early stages of carcinogenesis but tumour development and progression is impaired by lack of telomerase.((48,49)) The exception to this is in a p53-deficient background when p53 deficiency an…”
BackgroundTelomere function and regulation from mouse models to human ageing and disease
Jones-Weinert, C. W., Mainz, L., & Karlseder, J. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00800-5 · Cited by 68
“As discussed above, checkpoint responses to telomere dysfunction and crisis are probably distinct in mice; for example, short telomeres have been shown to limit tumorigenesis in a p53-dependent manner, even when driven by an activated oncogene 259–263 .”
Wang, J., Lu, X., Sakk, V., Klein, C. A., & Rudolph, K. L. (2014) · Blood · doi:10.1182/blood-2014-04-568055 · Cited by 57
“Moreover, the formation of chromosomal fusion represents an aberrant repair pathway that interferes with maintenance of chromosomal integrity in dividing cells.(11) Whether telomere shortening–induced DNA damage leads to accumulation of DNA damage and gene expression changes in HSCs, and whether these alterations are…”
Self-citationTransient telomere dysfunction induces chromosomal instability and promotes carcinogenesis
Begus-Nahrmann, Y., Hartmann, D., Kraus, J., Eshraghi, P., Scheffold, A., Grieb, M., Rasche, V., Schirmacher, P., Lee, H.-W., Kestler, H. A., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61745 · Cited by 54
“Studies on late-generation telomerase knockout mice with short telomeres (G3 mTerc –/– ) revealed that telomere shortening increases the rate of tumor initiation by induction of chromosomal instability (3, 7), especially when the p53 tumor-suppressor checkpoint is abrogated (9).”
BackgroundMethodInfluentialSelf-citationPerera, S. A., Maser, R. S., Xia, H., McNamara, K., Protopopov, A., Chen, L., F.Hezel, A., Kim, C. F., Bronson, R. T., Castrillon, D. H., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn050 · Cited by 56
“This is consistent with the hypothesis that cells with shortened telomeres experience crisis and undergo apoptosis when the p53 checkpoint is intact, but progress toward malignancy in the absence of p53 (5,6, 30 ,33,34).”
Self-citationMacKinnon, R. N., & Campbell, L. J. (2011) · Genetics Research International · doi:10.4061/2011/643628 · Cited by 64
“Studies of dicentric chromosomes in vivo, in vitro, and in mice with induced telomere dysfunction, support a major role for telomere erosion and subsequent end-to-end chromosome fusion in causing the genome instability which is observed in many types of cancer [6, 8, 21, 22, 24–26], although this has also recently bee…”
BackgroundMethodTelomeres and cancer: a tale with many endings
Blasco, M. A. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00011-4 · Cited by 62
Immunosenescence phenotypes in the telomerase knockout mouse
Blasco, M. A. (2002) · Springer Seminars in Immunopathology · doi:10.1007/s00281-001-0096-1 · Cited by 57
“In both genetic backgrounds the phenotypes associated to telomere dysfunction include (1) partial embryonic mortality due to a defect in the closure of the neural tube and to increased neuronal apoptosis [29]; (2) small size and severe intestinal atrophy [30, 54]; (3) spleen atrophy and reduced proliferation of B and…”
BackgroundTelomerase RNA Levels Limit the Telomere Length Equilibrium
GREIDER, C. W. (2006) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2006.71.063 · Cited by 57
“Genetic crosses between the mTR–/– mouse and several tumor-prone mouse models reveal that telo- mere shortening can limit tumor growth (Greenberg et al. 1999; Rudolph et al. 2001; Qi et al. 2003; Wong et al. 2003).”
BackgroundRegulation of Senescence in Cancer and Aging
Kong, Y., Cui, H., Ramkumar, C., & Zhang, H. (2011) · Journal of Aging Research · doi:10.4061/2011/963172 · Cited by 68
“Decreased tumorigenesis is also observed in late generation of mice with a null mutation in telomere catalytic subunit (mTERT−/−), and p53 mutation enables tumor progression in these mice [141].”
BackgroundTümpel, S., & Rudolph, K. L. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06547.x · Cited by 54
Self-citationTrková, M., Procházková, K., Krutilkova, V., Sumerauer, D., & Sedláček, Z. (2007) · Cancer · doi:10.1002/cncr.22834 · Cited by 61
Connecting mitotic instability and chromosome aberrations in cancer—can telomeres bridge the gap?
Gisselsson, D., & Höglund, M. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.09.002 · Cited by 59
Telomere dysfunction: multiple paths to the same end
Harrington, L. A., & Robinson, M. O. (2002) · Oncogene · doi:10.1038/sj.onc.1205084 · Cited by 65
“Furthermore, late generation mice lacking both telomerase activity and p53 exhibited an increased incidence of cancer relative to animals lacking only mTerc (Artandi et al., 2000; Rudolph et al., 2001).”
BackgroundTelomere fusions in early human breast carcinoma
Tanaka, H., Abe, S., Huda, N., Tu, L., Beam, M. J., Grimes, B., & Gilley, D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120062109 · Cited by 52
“Several studies have reported that anaphase bridges, possibly formed as a consequence of telomere dysfunction, are present in early-stage tumors, including DCIS (7, 10, 11).”
BackgroundKhoo, C. M., Carrasco, D. R., Bosenberg, M. W., Paik, J.-H., & DePinho, R. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700093104 · Cited by 52
Self-citationObesity-Associated Colorectal Cancer
Gonzalez-Gutierrez, L., Motiño, O., Barriuso, D., de la Puente-Aldea, J., Alvarez-Frutos, L., Kroemer, G., Palacios, R., & Senovilla, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168836 · Cited by 60
“Telomere dysfunction contributes to colorectal carcinogenesis The SNPs of the genes involved in the telomere structure, maintenance or length have been associated with CRC risks, as documented for the protection of telomeres 1 ( POT1 ) rs116895242, DNA cross-Figure 123].”
BackgroundTolerance of Chromosomal Instability in Cancer: Mechanisms and Therapeutic Opportunities
Gronroos, E. C., & López-García, C. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1958 · Cited by 71
Jin, X., Beck, S. J., Sohn, Y.-W., Kim, J.-K., Kim, S.-H., Yin, J., Pian, X., Kim, S.-C., Choi, Y.-J., & Kim, H. (2010) · Experimental & Molecular Medicine · doi:10.3858/emm.2010.42.8.058 · Cited by 55
“Although it is well documented that maintenance of telomere length, which is associated with tumor initiation and tumor cell proliferation, is one of the fundamental roles of telomerase, its other functions independent of telomere elongation have been also suggested that overexpression of telomerase promotes tumorigen…”
Zhang, A., Wang, J., Zheng, B., Fang, X., Ångström, T., Liu, C., Li, X., Erlandsson, F., Björkholm, M., Nordenskjörd, M., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207527 · Cited by 56
Bartocci, C., Diedrich, J. K., Ouzounov, I., Li, J., Piunti, A., Pasini, D., Yates, J. R., & Lazzerini Denchi, E. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.002 · Cited by 49
“Loss of end protection is frequently detected in human cancers such as colorectal carcinomas (Rudolph et al., 2001), oral squamous cell carcinomas (Gordon et al.”
BackgroundAugereau, A., T'kint de Roodenbeke, C., Simonet, T., Bauwens, S., Horard, B., Callanan, M., Leroux, D., Jallades, L., Salles, G., Gilson, E., et al. (2011) · Blood · doi:10.1182/blood-2010-07-295774 · Cited by 49
Use of Telomerase to Create Bioengineered Tissues
SHAY, J. W., & WRIGHT, W. E. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1356.037 · Cited by 49
Telomere Dysfunction, Chromosomal Instability and Cancer
Meena, J. K., Rudolph, K. L., & Güneş, Ç. (2015) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-20291-4_3 · Cited by 61
Self-citationSoohoo, C., Shi, R., Lee, T. H., Huang, P., Lu, K. P., & Zhou, X. Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.180174 · Cited by 56
Queisser, A., Heeg, S., Thaler, M., von Werder, A., & Opitz, O. G. (2013) · Cancer Genetics · doi:10.1016/j.cancergen.2013.10.001 · Cited by 50
Epigenetic control of telomerase and modes of telomere maintenance in aging and abnormal systems
Serene, R. L. (2005) · Frontiers in bioscience · doi:10.2741/1661 · Cited by 50
“Short-lived mammals such as Mus musculus lend fewer clues to human aging because of findings that telomerasenegative mice are normal for multiple generations (87) and overexpression of telomerase in mice does not alter aging as it does in human systems (88).”
BackgroundGordon, K., Ireland, H., Roberts, M., Steeghs, K., McCaul, J. A., MacDonald, D. G., & Parkinson, E. K. (2003) · PubMed · Cited by 50
Telomere length heterogeneity and chromosome instability
Londoño‐Vallejo, A. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.05.008 · Cited by 53
“[67] K.”
BackgroundTelomere dynamics in childhood leukemia and solid tumors: a follow-up study
Franco, S., Ozkaynak, M. F., Sandoval, C., Tugal, O., Jayabose, S., Engelhardt, M. M., & Moore, M. A. S. (2003) · Leukemia · doi:10.1038/sj.leu.2402815 · Cited by 46
Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes
Swiggers, S. J. J., Kuijpers, M. A., de Cort, M. J., Beverloo, H. B., & Zijlmans, J. M. J. M. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20286 · Cited by 47
“The presence of dysfunctional telomeres and subsequent breakage– fusion–bridge cycles has been suggested in humans in several types of solid tumors (Rudolph et al., 2001; Gisselsson et al., 2005; Stewenius et al., 2005).”
BackgroundTang, D., Zeng, T., Wang, Y., Cui, H., Wu, J., Zou, B., Tao, Z., Zhang, L., Garside, G. B., & Tao, S. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1714401 · Cited by 42
“Intestinal cross-sections through intestinal rolls spanning the entire small intestine were prepared as previously described.(61) Three-micrometer paraffin sections of the intestines were used for H&E staining.”
MethodTelomere length and telomerase subunits as diagnostic and prognostic biomarkers in Barrett carcinoma
Gertler, R., Doll, D., Maak, M., Feith, M., & Rosenberg, R. (2008) · Cancer · doi:10.1002/cncr.23419 · Cited by 47
“ating anaphase bridges; telomerase reactivation, however, was required secondarily for tumor progression.(28) Therefore, sufficient telomere maintenance in cancer cells promotes both unlimited proliferate capacity and stabilization of genomic abnormalities acquired in the initial state of critically short telomeres.”
BackgroundMechanisms of telomeric instability
Baird, D. M. (2008) · Cytogenetic and Genome Research · doi:10.1159/000167817 · Cited by 44
“…bridging, a surrogate marker of telomere fusion, is detected at the adenoma-carcinoma transition, a point that is characterised by increased chromosomal instability in colorectal carcinoma (Rudolph et al., 2001), breast (Chin et al., 2004) and oral squamous cell carcinomas (Gordon et al., 2003).”
BackgroundTelomere shortening and cell fates in mouse models of neoplasia
Artandi, S. E. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02222-5 · Cited by 40
Telomere dysfunction and stem cell ageing
Ju, Z., & Rudolph, K. L. (2007) · Biochimie · doi:10.1016/j.biochi.2007.09.006 · Cited by 48
Self-citationHong, S.-M., Heaphy, C. M., Shi, C., Eo, S.-H., Cho, H., Meeker, A. K., Eshleman, J. R., Hruban, R. H., & Goggins, M. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.181 · Cited by 39
Telomeres and Telomerase in Stem Cells during Aging and Disease
Ju, Z., & Rudolph, K. L. (2006) · KARGER eBooks · doi:10.1159/000092502 · Cited by 43
Self-citationTelomerase-dependent and -independent chromosome healing in mouse embryonic stem cells
Gao, Q., Reynolds, G. E., Wilcox, A., Miller, D. L., Cheung, P., Artandi, S. E., & Murnane, J. P. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.04.004 · Cited by 38
Telomerase inhibition and the future management of head-and-neck cancer
McCaul, J. A., Gordon, K., Clark, L., & Parkinson, E. K. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00729-5 · Cited by 44
Akbay, E. A., Peña, C. G., Ruder, D., Michel, J., Nakada, Y., Pathak, S., Multani, A. S., Chang, S. S., & Castrillón, D. H. (2012) · Oncogene · doi:10.1038/onc.2012.232 · Cited by 38
Wang, Y., Wang, X., Flores, E. R., Yu, J., & Chang, S. S. (2016) · Aging Cell · doi:10.1111/acel.12476 · Cited by 41
“In addition, dysfunctional telomeres also activate p53-dependent apoptotic proteins, including BAX and PUMA, to limit stem cell proliferation and suppress tumorigenesis (Chin et al., 1999; Gonzalez-Suarez et al., 2000; Rudolph et al., 2001; Begus- Nahrmann et al., 2009; Sperka et al., 2012a).”
BackgroundTelomeres in cancer and aging: lessons from the mouse
Blasco, M. A. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00705-x · Cited by 39
The Role of the APC Tumor Suppressor in Chromosomal Instability
Alberici, P., & Fodde, R. (2006) · KARGER eBooks · doi:10.1159/000092506 · Cited by 40
Deng, W., Tsao, S. W., Kwok, Y. K. Y., Wong, E., Huang, X. R., Liu, S., Tsang, C. M., Ngan, H., Cheung, A., Lan, H. Y., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6569 · Cited by 39
Intestinal Tumorigenesis in Min Mice is Enhanced by X-irradiation in an Age-dependent Manner
Okamoto, M., & Yonekawa, H. (2005) · Journal of Radiation Research · doi:10.1269/jrr.46.83 · Cited by 37
Nucleoplasmic bridges as a biomarker of DNA damage exposed to radon
Meenakshi, C., Sivasubramanian, K., & Venkatraman, B. (2016) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2016.12.004 · Cited by 35
Soo, J. K., Ross, A. D. M., Kallenberg, D. M., Milagre, C. S., Chong, W. H., Chow, J. W. M., Hill, L. J., Hoare, S. F., Collinson, R. S., Hossain, M., et al. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00850.x · Cited by 39
“Specifically, telomeric crisis phenotypes (including anaphase bridging) have been reported to peak at the stage of carcinoma in situ ⁄ early adenocarcinoma in human breast and colorectal cancers (Chin et al., 2004; Rudolph et al., 2001) and to be common in overt carcinoma in the pancreas and ovary (Hezel et al.”
InfluentialHarrington, L. A. (2003) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.12.007 · Cited by 40
KLF4 Suppresses Tumor Formation in Genetic and Pharmacological Mouse Models of Colonic Tumorigenesis
Ghaleb, A. M., Elkarim, E. A., Bialkowska, A. B., & Yang, V. W. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0410 · Cited by 35
“Additionally, a mutation in DNA helicase or telomerase in ApcMin/þmice increases the number of intestinal polyps because of high frequency of recombination and chromosomal instability (24).”
BackgroundPennaneach, V., & Kolodner, R. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006389 · Cited by 41
Different outcomes of telomere-dependent anaphase bridges
Tusell, L., Pampalona, J., Soler, D., Frías-López, C., & Genescà, A. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381698 · Cited by 38
Christensen, R., Alsner, J., Sørensen, F. B., Dagnæs‐Hansen, F., Kølvraa, S., & Serakıncı, N. (2008) · Regenerative Medicine · doi:10.2217/17460751.3.6.849 · Cited by 34
Telomerase: not just for the elongation of telomeres
Calado, R. T., & Chen, J. (2006) · BioEssays · doi:10.1002/bies.20365 · Cited by 34
Gisselsson, D., Gorunova, L., Höglund, M., Mandahl, N., & Elfving, P. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601803 · Cited by 36
“…sophisticated animal models, have suggested that neoplastic cell populations with short telomeres are dependent on the activation of telomerase in order to maintain telomere repeat length and continuing tumour cell proliferation (Greider, 1996; Artandi and DePinho, 2000; Rudolph et al, 2001).”
BackgroundTelomere fusion to chromosome breaks reduces oncogenic translocations and tumour formation
Qi, L., Strong, M. A., Karim, B. O., Huso, D. L., & Greider, C. W. (2005) · Nature Cell Biology · doi:10.1038/ncb1276 · Cited by 32
“5781 23wk n=21 +15 t(6;13), t(12;11), t(11;14), t(13;6), t(2;4;2), t(11;3), t(1;19), t(1;13), t(9;13), t(3;4), t(19;6), t(14;6;2), t(11;16), t(t(12;11);3), t(6;19), t(4;3), t(19;18), t(17;15), t(12;14), t(10;1), f(t(12;11); 14), f(t(12;11);t(12;11)); f(15p;15p), f(17q;15p), f(15p;16p),f(15p;3p), f(11p;12p); frag(1).”
InfluentialTelomeric impact of conventional chemotherapy
Lu, Y., Leong, W., Guérin, O., Gilson, É., & Ye, J. (2013) · Frontiers of Medicine · doi:10.1007/s11684-013-0293-z · Cited by 34
“On the other hand, telomere shortening cooperates with p53 deficiency to favour carcinogenesis in aged mice [26].”
BackgroundThe Power of Stress: The Telo-Hormesis Hypothesis
Burbano, M. S. J., & Gilson, É. (2021) · Cells · doi:10.3390/cells10051156 · Cited by 41
Kotiyal, S., & Evason, K. J. (2021) · Cancers · doi:10.3390/cancers13164202 · Cited by 33
“Terc (mouse) Whole body − ↑ adenoma initiation but ↓ progression in ApcMin mice [30]”
BackgroundHeller-Uszyńska, K., Schnippenkoetter, W., & Kilian, A. (2002) · The Plant Journal · doi:10.1046/j.1365-313x.2001.01337.x · Cited by 34
Evolution of genetic instability in heterogeneous tumors
Asatryan, A. D., & Komarova, N. L. (2016) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2015.11.028 · Cited by 37
“Paper [44] studies intestinal carcinoma in mice and humans, and reports data which are consistent with a similar model: telomere dysfunction promotes chromosomal instability, which in turn drives carcinogenesis at early stages.”
BackgroundModeling aging and cancer in the telomerase knockout mouse
Chang, S. S. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.08.020 · Cited by 37
Telomeres and Telomerase: A Modern Fountain of Youth?
de Magalhães, J. P., & Toussaint, O. (2004) · Rejuvenation Research · doi:10.1089/1549168041553044 · Cited by 36
The telomerase cycle: normal and pathological aspects
Brunori, M., Luciano, P., Gilson, É., & G�li, V. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0616-2 · Cited by 33
“Second, strong chromosomal instability is observed during the onset of various human cancers, including colon cancer [153].”
BackgroundSfeir, A. J. (2012) · Journal of Cell Science · doi:10.1242/jcs.106831 · Cited by 43
“Many solid tumors, including those of the breast (Chin et al., 2004), prostate (Meeker et al., 1996) and colon (Rudolph et al., 2001), have shorter telomeres when compared with those of the respective normal tissue.”
BackgroundDual roles of telomere dysfunction in initiation and suppression of tumorigenesis
Cosme‐Blanco, W., & Chang, S. S. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.03.011 · Cited by 32
“The link between telomere shortening and tumor suppression is further highlighted in the mTerc−/−ApcMin mouse (Rudolph et al., 2001).”
BackgroundIqbal, K., Kues, W. A., Baulain, U., Garrels, W., Herrmann, D., & Niemann, H. J. (2010) · Biology of Reproduction · doi:10.1095/biolreprod.110.087205 · Cited by 33
Telomere Dysfunction and DNA Damage Checkpoints in Diseases and Cancer of the Gastrointestinal Tract
Rudolph, K. L., Hartmann, D., & Opitz, O. G. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.037 · Cited by 33
Self-citationLengauer, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231485898 · Cited by 35
Xu, X., Qu, K., Pang, Q., Wang, Z., Zhou, Y., & Liu, C. (2016) · Frontiers of Medicine · doi:10.1007/s11684-016-0450-2 · Cited by 31
“However, although telomere maintenance is common in advanced malignancies, evidence suggests that short telomeres with concurrent chromosomal instability would result in malignant transformation in normal cells [5,6].”
BackgroundCause-specific telomere factors deregulation in hepatocellular carcinoma
Idrissi, M. E., Hervieu, V., Merle, P., Mortreux, F., & Wattel, E. (2013) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-32-64 · Cited by 28
“During early tumor development, hTERT is frequently expressed and allows the clone to bypass mitotic catastrophe and replicative senescence, contributing to malignant immortalization [4,5,19-21].”
Duan, X., Yang, Y., Zhang, D., Wang, S., Feng, X., Wang, T., Wang, P., Ding, M., Zhang, H., Liu, B., et al. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.05.134 · Cited by 28
Building bridges between chromosomes: novel insights into the abscission checkpoint
Petsalaki, E., & Zachos, G. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03224-z · Cited by 28
Pantić, M., Zimmermann, S., Daly, H. E., OPITZ, O. G., Popp, S., Boukamp, P., & Martens, U. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209486 · Cited by 32
“Similarly, a peak in ABI has been reported to occur in early high-grade dysplastic lesions and less in more advanced carcinoma stages (Rudolph et al., 2001).”
BackgroundPirzio, L. M., Freulet-Marrière, M.-A., Bai, Y., Fouladi, B., Murnane, J. P., Sabatier, L., & Desmaze, C. (2004) · Cytogenetic and Genome Research · doi:10.1159/000077470 · Cited by 29
“…of telomerase in tumor or senescent cells after initiation of genetic instability, may accumulate complex karyotypes by perpetuating instability (Chadeneau et al., 1995; Tang et al., 1998; Ducray et al., 1999; DePinho, 2000; Fouladi et al., 2000; Rudolph et al., 2001; Mondello et al., 2003).”
BackgroundTakubo, K., Aida, J., Izumiyama, N., Ishikawa, N., Fujiwara, M., Poon, S. S. S., Kondo, H., Kammori, M., Matsuura, M., Sawabe, M., et al. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.08.007 · Cited by 27
“Anaphase bridges have been described only occasionally in human neoplasms (Gisselsson et al., 2000; Rudolph et al., 2001).”
Backgroundvan Ockenburg, S. L., de Jonge, P., van der Harst, P., Ormel, J., & Rosmalen, J. G. M. (2013) · Psychological Medicine · doi:10.1017/s0033291713001657 · Cited by 31
“One possibility is that telomere shortening is part of the mechanism by which neuroticism leads to increased mortality rates through, for instance, chromosomal instability (Rudolph et al. 2001) and cell senescence (Collado et al. 2007).”
Telomerase regulation in hematological cancers: A matter of stemness?
Deville, L., Hillion, J., & Ségal-Bendirdjian, E. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.01.016 · Cited by 29
“This finding has implications for therapy as telomere dysfunction could limit the therapeutic potential of transplanted cells and also could contribute to the increase cancer initiation that has been observed in aging telomere-dysfunctional mice [90].”
BackgroundProtective role for lipid modifications of Src-family kinases against chromosome missegregation
Honda, T., Soeda, S., Tsuda, K., Yamaguchi, C., Aoyama, K., Morinaga, T., Yuki, R., Nakayama, Y., Yamaguchi, N., & Yamaguchi, N. (2016) · Scientific Reports · doi:10.1038/srep38751 · Cited by 31
Wang, H., Zhang, K., Liu, Y., Fu, Y., Gao, S., Gong, P., Wang, H., Zhou, Z., Zeng, M., Wu, Z., et al. (2017) · BMC Biology · doi:10.1186/s12915-017-0453-8 · Cited by 27
Güneş, Ç., Avila, A. I., & Rudolph, K. L. (2017) · Differentiation · doi:10.1016/j.diff.2017.12.004 · Cited by 30
Self-citationTRF2 inhibition promotes anchorage-independent growth of telomerase-positive human fibroblasts
Brunori, M., Mathieu, N., Ricoul, M., Bauwens, S., Koering, C., de Climens, A. R., Belleville, A., Wang, Q., Puisieux, I., Décimo, D., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209135 · Cited by 29
“…other hand, studies on mice lacking the telomerase RNA gene demonstrate that critical telomere shortening and telomere instability can favor initial stages of cancer formation and cooperates with p53 deficiency to favor carcinogenesis (Chin et al., 1999; Artandi et al., 2000; Rudolph et al., 2001).”
BackgroundInfluentialLi, Y., Sundquist, K., Wang, X., Zhang, N., Hedelius, A., Sundquist, J., & Memon, A. A. (2021) · Cancers · doi:10.3390/cancers13153842 · Cited by 27
Telomere dysfunction is related to the intrinsic radio-resistance of human oral cancer cells
McCaul, J. A., Gordon, K., Minty, F., Fleming, J., & Parkinson, E. K. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2007.02.010 · Cited by 28
Castro‐Vega, L. J., Jouravleva, K., Liu-Bordes, W.-Y., Martinez, C., Gestraud, P., Hupé, P., Servant, N., Albaud, B., Gentien, D., Gad, S., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt029 · Cited by 29
Duan, X., Zhang, D., Wang, S., Feng, X., Wang, T., Wang, P., Ding, M., Zhang, H., Liu, B., Wei, W., et al. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.135600 · Cited by 25
Prognostic Significance of Telomerase Polymorphism in Non–Small Cell Lung Cancer
Catarino, R., Araújo, A., Coelho, A., Gomes, M. P., Nogueira, A., Lopes, C., & Medeiros, R. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3030 · Cited by 27
“In fact, telomere dysfunction (short telomeres) has been associated with the initiation and progression of human neoplasia (13).”
BackgroundDifferences in telomerase activity between colon and rectal cancer
Ayiomamitis, G. D., Notas, G., Zaravinos, A., Zizi-Sermpetzoglou, A., Γεωργιάδου, Μ., Sfakianaki, O., & Kouroumallis, E. (2014) · Canadian Journal of Surgery · doi:10.1503/cjs.031312 · Cited by 27
“Furthermore, it has been reported that it is possible that both high telomerase, by conferring cellular immortality, and low telomerase, by promoting CIN, increase the risk of cancer.(41) Our results indicate that high telomerase activity in the colon is associated with the”
BackgroundREVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY
Lynch, J. P., Metz, D. C., Schuppan, D., Junker, Y., & Barisani, D. (2009) · Cited by 24
Gashi, G., Mahovlić, V., Manxhuka-Kërliu, S., Podrimaj-Bytyqi, A., Gashi, L., & Elezaj, I. R. (2018) · Biomarkers · doi:10.1080/1354750x.2018.1428828 · Cited by 26
Yoshida, K., Hamai, Y., Suzuki, T., Sanada, Y., Oue, N., & Yasui, W. (2006) · PubMed · Cited by 24
Wiemann, S. U., Ande, S., Buer, J., Kamino, K., Manns, M. P., & Rudolph, K. L. (2004) · Oncogene · doi:10.1038/sj.onc.1208308 · Cited by 24
Self-citationPRL-3 promotes telomere deprotection and chromosomal instability
Lian, S., Meng, L., Yang, Y., Ma, T., Xing, X., Feng, Q. F., Song, Q., Liu, C., Tian, Z., Qu, L., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx392 · Cited by 26
“Several conditions could increase anaphase bridge formation, including mutations in telomeric DNA (75), removal of shelterin components (76), telomere shortening (55) and telomere crisis induced by replication inhibitors, such as aphidicolin (77).”
BackgroundSuppression of human tumor cell proliferation by Smurf2‐induced senescence
Zhang, H., Teng, Y., Kong, Y., Kowalski, P. E., & Cohen, S. N. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21337 · Cited by 23
“…in these cells (Prowse and Greider, 1995; Greenberg et al., 1998), undergo gradual loss of telomeres and induction of senescence, and become resistant to neoplasia (Greenberg et al., 1999; Gonzalez-Suarez et al., 2000; Rudolph et al., 2001; Cosme-Blanco et al., 2007; Feldser and Greider, 2007).”
BackgroundCancer stem cells—clinical relevance
Jones, R. J. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0534-4 · Cited by 23
“In fact, crossing telomerase knock-out mice with INK4a [36] or APC [37] mice predisposed to cancer, significantly lowered the development of cancers in these mice.”
BackgroundTelomeres: Dysfunction, Maintenance, Aging and Cancer
Liao, P., Yan, B., Wang, C., & Lei, P. (2023) · Aging and Disease · doi:10.14336/ad.2023.1128 · Cited by 36
“The complex involvement of telomeres in tumorigenesis was shown by these mouse models, particularly how dysfunctional telomeres promote tumorigenesis while preventing complete malignant transformation [123,137].”
InfluentialSenescence as a modulator of oral squamous cell carcinoma development
Parkinson, E. K. (2010) · Oral Oncology · doi:10.1016/j.oraloncology.2009.09.009 · Cited by 25
Frijhoff, A. F. W., Conti, C. J., & Senderowicz, A. M. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.20013 · Cited by 24
Telomere Shortening and Fusions: A Link to Aneuploidy in Early Human Embryo Development
Kohlrausch, F. B., Wang, F., Chamani, I. J., & Keefe, D. L. (2021) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000907 · Cited by 24
Metadata
- Authors
- Rudolph, K. L., Millard, M., Bosenberg, M. W., & DePinho, R. A.
- Affiliations
- Dana-Farber Cancer Institute (US)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Corresponding author
- DePinho, Ronald A.
- Venue
- Nature Genetics
- Published
- 2001-06
- Volume
- 28
- Issue
- 2
- Pages
- 155-159
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1483245334
- Cited by
- 527
- References
- 31
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 9 · 2023: 10 · 2022: 8 · 2021: 13 · 2020: 8 · 2019: 12 · 2018: 11 · 2017: 10 · 2016: 16 · 2015: 18 · 2014: 16 · 2013: 26 · 2012: 27
- FWCI
- 26.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- telomere dysfunction, telomerase activation, colorectal carcinogenesis, chromosomal instability, ApcMin/+ mice, TP53 mutation, anaphase bridges, tumor progression, tumor initiation, genome stability
- MeSH terms
- Adenocarcinoma, Adenoma, Animals, Cytoskeletal Proteins, Humans, Intestinal Neoplasms, Mice, Inbred C57BL, Mice, Mutant Strains, RNA, Colorectal Neoplasms, Tumor Suppressor Protein p53, Telomere, Apoptosis, Telomerase, Adenomatous Polyposis Coli Protein, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.